Humana Inc. diskutieren
Humana Inc.
WKN: 856584 / Symbol: HUM / Name: Humana / Aktie / Anbieter & Dienstleistungen / Large Cap /
316,20 €
-0,54 %
Buy Humana Inc.
Buy Humana Inc.
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $575.00 to $562.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $637.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target raised by analysts at Stephens from $555.00 to $560.00. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at TD Cowen from $616.00 to $613.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $597.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target raised by analysts at Jefferies Financial Group Inc. from $580.00 to $586.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $597.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $630.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $595.00 to $515.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Royal Bank of Canada from $599.00 to $507.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $597.00 price target on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $515.00 to $450.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Royal Bank of Canada from $507.00 to $415.00. They now have an "outperform" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Stephens from $550.00 to $430.00. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Mizuho from $550.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat
Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Wells Fargo & Company from $465.00 to $413.00. They now have an "overweight" rating on the stock.
Ratings data for HUM provided by MarketBeat
Neueste Beiträge
Roth_Mkm in Semtech Corp. diskutieren